You are here: Home » PTI Stories » National » News
Business Standard

USFDA completes inspection of Nagpur facility, no observation issued: Lupin

Press Trust of India  |  New Delhi 

Drug firm Friday said the US health regulator has completed inspection of its facility in without any observation.

The product specific pre-approval inspection by USFDA concluded without any observation, said in a BSE filing.

Shares of were trading at Rs 972.80 apiece, up 1.72 per cent, from the previous close on BSE.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, September 14 2018. 12:00 IST